Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
3
×
life sciences
national blog main
new york blog main
3
×
biotech
boston blog main
new york
new york top stories
san diego blog main
san diego top stories
achaogen
adams street partners
akcea therapeutics
alirocumab
alnylam pharmaceuticals
amgen
antibiotics
anylam pharmaceuticals
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
boston top stories
cardiomyopathy
deals
drug resistance
evercore isi
evolocumab
fda
hatteras venture partners
heart attack
inclisiran
inotersen
investing
joseph swartz
lyzz capital
macrolide pharmaceuticals
medicines co.
melinta therapeutics
meropenem
michael dudley
What
drug
medicines
3
×
alnylam
disease
year
ago
akcea
amyloidosis
approved
attr
available
bacteria
based
battle
biopharma
business
cholesterol
company
data
debilitating
evidence
exited
fda
fighting
genetic
heart
infections
infectious
lasting
launches
long
looms
lowering
medco
melinta
new
oks
partner
patients
pfizer
Language
Current search:
medicines
×
drugs
×
" new york blog main "
×
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
4 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections